PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support specific specialties and conditions. Each episode includes a link to request CME/CE credit for participation. PeerView is solely responsible for the selection of topics, the preparation of editorial content, and the distribution of all materials it publishes.
Subscribe
| Title
|
Date published
|
|
|
|
Anita H. Clayton, MD - Recent Advances in the Management of Depressive Disorders: Preparing for a Shift in the Treatment Paradigm
|
2022-04-29
|
|
|
|
Gregory W. Albers, MD / S. Claiborne “Clay” Johnston, MD, PhD - Mastering the Use of Dual Antiplatelet Therapy for Preventing Recurrent Stroke: How Well Do Your Current Strategies Match With the Experts?
|
2022-04-15
|
|
|
|
Julie Parsons, MD - Breakthroughs in Spinal Muscular Atrophy: Managing the Life-Changing Impact of Gene Replacement Therapy
|
2022-04-15
|
|
|
|
Amit Bar-Or, MD, FRCPC / Daniel S. Reich, MD, PhD - Rationale, Evidence, and Practical Potential for BTK Inhibitors in Patient-Centered MS Care: Where We Stand Now
|
2022-04-04
|
|
|
|
"Mark S. Freedman, MD - Leveraging S1PR Modulators to Provide Patient-Centered MS Care: An Expert-Driven Review of the Data"
|
2022-03-29
|
|
|
|
Tammie L.S. Benzinger - The Expanding Role of Neuroimaging in Alzheimer’s Disease Diagnosis and Management: Is Radiology Prepared for New Challenges?
|
2022-03-01
|
|
|
|
Alan "Tony" Amberg - Addressing Unmet Needs in the Management of Schizophrenia and Bipolar Disorder: New and Emerging Therapeutic Options to Enhance Treatment and Maximize Patient Outcomes
|
2022-02-23
|
|
|
|
Anita H. Clayton, MD - Recent Advances and Novel Options in Depression: Reviewing the Evidence for GABA-Modulating Neuroactive Steroids for Major Depressive Disorder
|
2022-02-15
|
|
|
|
Steven Brem, MD - A New Wave of Progress in Glioblastoma: Expert Guidance on Delivering Modern Personalized Care With Tumor Treating Fields and Novel Systemic Approaches
|
2022-01-26
|
|
|
|
Lenard A. Adler, MD / Oren Mason, MD - Overcoming Challenges in the Recognition and Management of Adult ADHD in Primary Care: Optimizing Outcomes to Reduce Disease Burden and Improve Quality of Life
|
2022-01-11
|
|
|
|
Erik P. Sulman, MD, PhD - Implementing Synergistic Multimodal Approaches With Tumor Treating Fields to Extend Survival in Aggressive Cancers
|
2021-12-08
|
|
|
|
Benjamin M. Greenberg, MD, MHS & Professor Anthony Traboulsee, MD - Bruton Tyrosine Kinase Inhibitors for MS: Progress in the Development of an Emerging Therapeutic Approach
|
2021-12-08
|
|
|
|
Bruce Cree, MD, PhD, MAS - Exploring the Convergence of Advances in S1P Receptor Modulation With Progress in Understanding Brain Atrophy and Cognition Measures in Multiple Sclerosis
|
2021-11-22
|
|
|
|
Professor Dame Pamela J. Shaw - On the Cusp of a New Targeted Treatment Era in ALS: Exploring the Emerging Therapeutic Landscape
|
2021-11-03
|
|
|
123
